分析:在炎症性肠病中饮食障碍的患病率
Quinn Goddard1,2, Ante Markovinović1,2, Paul E Ronksley2
1Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Alimentary pharmacology & therapeutics
|December 27, 2025
概括
饮食障碍在炎症性肠病 (IBD) 患者中很常见,尤其是避免性/限制性类型. 提高临床意识和查对于更好地检测和管理这一群体中饮食失调至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 饮食失调和炎症性肠病 (IBD) 之间的关系尚不清楚,关于因果关系的争论仍在进行中.
- 现有的研究缺乏对IBD人口中饮食障碍患病率的全面估计.
研究的目的:
- 进行最新的系统审查和首次元分析,以确定被诊断为IBD的个体中饮食障碍的流行率.
- 确定影响流行率估计的因素,如评估方法和患者人口统计数据.
主要方法:
- 系统地搜索主要的生物医学数据库 (MEDLINE,Embase,PsycINFO) 到2025年10月.
- 包括报告IBD患者饮食障碍患病率的原始观察性研究.
- 使用随机效应模型计算聚合流行率,按子组分层,并评估异质性.
主要成果:
- 包括23项研究,揭示了基于评估工具的流行率的显著变化.
- 自我报告问卷显示综合患病率为13.60%,而医生诊断显示为2.84%.
- 九项避免/限制性食物摄入障碍查结果显示,患病率最高,为17.10%;没有根据性别,IBD亚型,年龄或疾病活性发现显著差异.
结论:
- 饮食障碍,特别是避免/限制类型,在IBD患者中很普遍.
- 这些发现强调了加强查方案的必要性,并提高了IBD患者队列中饮食失调的临床意识.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
609
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
609
Inflammatory Bowel Disease II: Crohn's Disease
912
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
912
Chronic Bowel Disorders: Introduction
722
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
722
Inflammatory Bowel Disease I: Ulcerative Colitis
854
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
854
Inflammatory Bowel Disease IV: Pharmacological Management
439
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
439
Irritable Bowel Syndrome I: Introduction
885
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
885


